New Universal Nasal Spray Vaccine Promises Broad Protection Against Colds, Flu, and Allergies

In what experts are calling a "radical departure" from traditional immunology, Stanford Medicine researchers have developed an experimental vaccine that could one day spell the end of the seasonal cold, flu, and even allergies.

Published recently in the journal Science, the study reveals a new nasal spray vaccine that has successfully protected mice against a remarkably wide spectrum of respiratory threats. According to the research, a few drops in the nose defended the animals against SARS-CoV-2, influenza, bacterial infections like Staphylococcus aureus, and even common allergens like house dust mites.

For over 230 years, vaccines have relied on "antigen specificity," a process that trains the body to fight one specific infection, such as the measles or a particular strain of the flu. However, because viruses frequently mutate, these highly specific vaccines often lose their potency, which is why annual flu shots and COVID-19 boosters are necessary.

This new vaccine formulation, currently known as GLA-3M-052-LS+OVA, takes an entirely different approach. Instead of copying a piece of a specific virus, it mimics the communication signals that immune cells exchange during an infection.

Delivered via nasal spray, the vaccine supercharges the body's innate immune system, leaving white blood cells in the lungs on an "amber alert" for several months. In animal experiments, this heightened state of readiness led to a 700-fold reduction of viral levels in the lungs. Any pathogens that managed to slip past this initial defense were swiftly met by a rapid adaptive immune response, neutralizing the threat in a matter of days rather than weeks.

While independent experts, such as Professor Daniela Ferreira of the University of Oxford, have praised the research as "really exciting" and a potential "major step forward," hurdles remain. Human clinical trials are the next vital step. Researchers note that the vaccine might need to be administered via a nebulizer to reach deep into human lungs, and they must ensure that keeping the immune system on high alert does not trigger "friendly fire" or unwanted autoimmune side effects.

If future trials are successful and adequately funded, Dr. Bali Pulendran, the study's senior author, estimates that this universal vaccine could become available in five to seven years. Ultimately, it could serve as a powerful bulwark against future pandemics and drastically simplify seasonal medical care.

---

🔖 Sources

Scientists create universal nasal spray vaccine that protects against COVID, flu, and pneumonia

One vaccine may provide broad protection against many respiratory infections and allergens

Single vaccine could protect against all coughs, colds and flus, researchers say

---

Keywords: Universal Nasal Spray Vaccine

Universal Nasal Spray Vaccine

---